Vasopressor Infusion in Cesarean Delivery

• Status: Recruiting
• Trial end date: 2022-03-10
• Target enrollment: 0
• Participant gender: Female

Summary

Comparison will be conducted between continuous variable infusions of both drugs (Phenylephrine and Norepinephrine) with starting doses of 0.75 mcg/Kg/min and 0.1 mcg/Kg/min respectively for prophylaxis against Post-spinal hypotension during cesarean delivery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Bupivacaine; Norepinephrine; Oxymetazoline; Phenylephrine

Criteria

Inclusion Criteria:

• full term

• pregnant women

• scheduled for cesarean section

Exclusion Criteria:

• pre-ecpamsia

• eclampsia

• bleeding

• cardiac dysfuction